Not applicableEnded earlyNCT01100749What this trial is testingChronic Hepatitis C (CHC) - Genotype 3 Infection in CanadaWho this might be right forChronic Hepatitis C - Genotype 3 University Health Network, Toronto 25
Not applicableActive Not RecruitingNCT07316842What this trial is testingSVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOFWho this might be right forViral Hepatitis C Center of target therapy 30
Large-scale testing (Phase 3)Study completedNCT01604850What this trial is testingSofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)Who this might be right forChronic Hepatitis C Gilead Sciences 202
Testing effectiveness (Phase 2)Study completedNCT02094443What this trial is testingAlisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an OptionWho this might be right forHepatitis CLiver Disease Debiopharm International SA 52
Large-scale testing (Phase 3)Study completedNCT03090035What this trial is testingImpact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C TreatmentWho this might be right forHepatitis CHepatitis C Relapse Sheikh Zayed Medical College 98
Large-scale testing (Phase 3)Study completedNCT02114151What this trial is testingEfficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and CirrhosisWho this might be right forHepatitis C Virus Infection Janssen Infectious Diseases BVBA 103
Testing effectiveness (Phase 2)Study completedNCT02068222What this trial is testingEvaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) InfectionWho this might be right forChronic Hepatitis CHepatitis C Virus AbbVie 10
Testing effectiveness (Phase 2)Study completedNCT01121731What this trial is testingA Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis CWho this might be right forChronic Hepatitis C Virus InfectionGenotype 1Treatment-Experienced Patients+1 more Digna Biotech S.L. 70
Testing effectiveness (Phase 2)Study completedNCT00759200What this trial is testingSafety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C PatientsWho this might be right forChronic Hepatitis C Novartis 525
Large-scale testing (Phase 3)Study completedNCT01896193What this trial is testingSafety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV InfectionWho this might be right forHepatitis C Gilead Sciences 127
Not applicableStudy completedNCT00700401What this trial is testingPOTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin).Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 262
Testing effectiveness (Phase 2)Ended earlyNCT01440595What this trial is testingGrazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 5
Large-scale testing (Phase 3)Study completedNCT01962441What this trial is testingSOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV InfectionWho this might be right forHepatitis C Gilead Sciences 601
Post-approval studies (Phase 4)Study completedNCT01258101What this trial is testingPEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 395
Testing effectiveness (Phase 2)Ended earlyNCT02759315What this trial is testingEfficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)Ended earlyNCT02956629What this trial is testingEfficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041)Who this might be right forHepatitis C Merck Sharp & Dohme LLC 282
Large-scale testing (Phase 3)Study completedNCT01544920What this trial is testingSafety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 737
Large-scale testing (Phase 3)Study completedNCT02032888What this trial is testingEvaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.Who this might be right forHepatitis C Bristol-Myers Squibb 238
Testing effectiveness (Phase 2)Study completedNCT01260350What this trial is testingOpen-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3Who this might be right forChronic Hepatitis C Infection Gilead Sciences 292
Early research (Phase 1)Study completedNCT02339207What this trial is testingFirst in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1Who this might be right forChronic Hepatitis C Alios Biopharma Inc. 112